BioNexus Gene Lab (BGLC) Short-Term Debt repayments (2018 - 2026)
BioNexus Gene Lab recorded quarterly Short-Term Debt repayments of $80717.0 in Q1 2026, up 16340.85% quarter-over-quarter from -$497.0 in Q4 2025, and up 9485.7% year-over-year from $842.06 in Q1 2025.
BioNexus Gene Lab's Short-Term Debt repayments history runs 6 years deep, the most recent figure standing at $80717.0 for Q1 2026.
- In Q1 2026, Short-Term Debt repayments rose 9485.7% year-over-year to $80717.0; the TTM figure through Mar 2026 stood at $113882.0 (up 157.16% YoY), while the FY2025 annual figure was $32305.0, up 712.7% from the prior year.
- Short-Term Debt repayments came in at $80717.0 for Q1 2026 at BioNexus Gene Lab, up from -$497.0 in the prior quarter.
- In the past five years, Short-Term Debt repayments ranged from a high of $80717.0 in Q1 2026 to a low of -$196982.0 in Q3 2024.
- A 3-year average of -$12192.4 and a median of -$525.0 in 2025 frame the typical range for Short-Term Debt repayments.
- Across the five-year window, Short-Term Debt repayments jumped 64.17% in 2025 and jumped 9485.7% in 2026, its largest moves.
- BioNexus Gene Lab's Short-Term Debt repayments stood at -$1387.0 in 2024, then jumped by 64.17% to -$497.0 in 2025, then surged by 16340.85% to $80717.0 in 2026.
- According to Business Quant data, Short-Term Debt repayments over the past three periods registered $80717.0, -$497.0, and $34187.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Linde | 230.79 Bn | 226.84 Bn | 4.26 Bn | - |
| 2 | Chemical & Mining Co Of Chile | 127.66 Bn | 124.93 Bn | 778.60 Mn | - |
| 3 | Sherwin Williams | 72.51 Bn | 72.30 Bn | 2.78 Bn | - |
| 4 | Ecolab | 70.96 Bn | 70.34 Bn | 1.85 Bn | - |
| 5 | Air Products & Chemicals | 62.15 Bn | 63.70 Bn | 987.40 Mn | - |
| 6 | Ppg Industries | 25.04 Bn | 23.57 Bn | 1.66 Bn | - |
| 7 | LyondellBasell Industries | 21.62 Bn | 21.73 Bn | 701.00 Mn | - |
| 8 | Albemarle | 20.26 Bn | 19.42 Bn | 500.97 Mn | - |
| 9 | DuPont de Nemours | 19.45 Bn | 19.56 Bn | 602.00 Mn | - |
| 10 | BioNexus Gene Lab | 5.34 Mn | 1.38 Mn | -790.00 | 80,717.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 80,717.00 |
| Mar 31, 2026 | 80,717.00 |
| Dec 31, 2025 | -497.00 |
| Dec 31, 2025 | -497.00 |
| Sep 30, 2025 | 34,187.00 |
| Sep 30, 2025 | 34,187.00 |
| Dec 31, 2024 | -1,387.00 |
| Dec 31, 2024 | -1,387.00 |
| Sep 30, 2024 | -196,982.00 |
| Sep 30, 2024 | -196,982.00 |
| Jun 30, 2020 | -3.00 |
| Jun 30, 2020 | -3.00 |
| Mar 31, 2020 | -368.00 |
| Mar 31, 2020 | -368.00 |
| Dec 31, 2019 | -181.00 |
| Dec 31, 2019 | -181.00 |
| Sep 30, 2019 | -98.00 |
| Sep 30, 2019 | -98.00 |
| Dec 31, 2018 | 1,273.00 |
| Dec 31, 2018 | 1,273.00 |